ProRx LLC recalls Semaglutide
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Semaglutide
- Company
- ProRx LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 2,490 vials
- About this recall
- Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01